Focusrite PLC reports solid final results with revenue up, margins improved, net debt halved and a new proprietary silicon platform unveiled for future growth.
This article covers information on Focusrite PLC.
LON:TUNEFocusrite has put out a solid, slightly complicated set of numbers – complicated because this is an 18-month reporting period after changing its year end to 28 February. The cleanest way to judge the business is the company’s pro-forma 12-month comparison to February 2026 versus February 2025.
On that basis, this was a respectable update. Revenue edged up, margins improved nicely, adjusted EBITDA rose, and net debt dropped sharply. That is not a flashy growth story, but it is the sort of steady operational progress that matters when consumer markets are patchy and tariffs are causing chaos.
| Metric | 12 months to 28 February 2026 | 12 months to 28 February 2025 | Change |
|---|---|---|---|
| Revenue | £164.6 million | £162.5 million | +1.3% |
| Gross margin | 45.1% | 43.4% | +1.7 percentage points |
| Adjusted EBITDA | £24.7 million | £23.3 million | +5.7% |
| Adjusted operating profit | £15.1 million | £14.9 million | +1.3% |
| Adjusted diluted EPS | 15.6p | 16.9p | -7.7% |
| Net debt | £8.6 million | £17.9 million | Improved by £9.3 million |
The headline snag is that reported operating profit flipped to a loss of £0.9 million from a profit of £4.0 million. But that was mainly because of a £9.8 million non-cash impairment charge against Sequential assets. Non-cash means money did not leave the bank account now, but it does tell you management thinks those assets are worth less than previously believed.
At first glance, 1.3% revenue growth is hardly thrilling. But there are a few important caveats.
First, currency was a headwind. Focusrite said exchange rate movements knocked around £2.3 million off revenue, mainly due to a weaker US dollar. Second, US sales were deliberately pulled forward in the prior year to get ahead of tariff changes, which makes this year’s comparison tougher.
Strip that out, and organic constant currency growth was 2.7%. Adjusting for the US sales phasing, underlying growth was 6.9% on an OCC basis. In plain English, the business probably did better than the headline suggests.
That mix matters. Content Creation includes core music-making products such as Focusrite audio interfaces, Novation controllers and ADAM Audio monitors. Audio Reproduction covers professional sound systems for live events and installations. One side is more consumer-facing, the other more project and venue-led, so having both helps balance the group.
The best line in this release, in my view, is the margin improvement. Gross margin rose to 45.1% from 43.4%, which is a meaningful step up.
Management credits disciplined pricing, supply chain moves and better direct-to-consumer sales. That stacks up. Tariffs were all over the place, especially in the US, yet Focusrite still protected profitability. That tells you the brands have pricing power and the operations team has been busy in the right way.
Cash was good too. Underlying free cash inflow was £12.9 million for the 12 months to February 2026, and net debt fell to £8.6 million from £17.9 million. The main driver was better working capital, with reductions in inventory and debtors.
That is important because it gives Focusrite more breathing room. Less debt means less financial strain, more flexibility to invest, and a bit more resilience if markets wobble again.
There is also a quality angle to these results. Focusrite’s direct-to-consumer eCommerce business kept growing, and for the six months to February 2026 it represented 12% of Content Creation revenue.
Why care? Because selling direct usually means better control over pricing, customer data, product mix and margins. It also makes repeat sales easier. That tends to be better business than relying entirely on third-party channels.
The group also launched a new direct-to-reseller route in Japan. Management said this has already helped brand awareness, market share and gross margin in markets where it has been rolled out, including the UK, Germany, Australia and now Japan.
This was not a spotless update. The biggest weak spot is Sequential, the premium synthesiser business.
Focusrite said the market for premium synthesisers is difficult, especially in the US. Tariffs hurt because synthesisers did not qualify for some exemptions, and the company’s US contract manufacturer is ceasing operations, forcing a faster relocation to a non-US manufacturer. That combination led to the £9.8 million impairment.
There is also the earnings issue. Adjusted diluted EPS fell 7.7% to 15.6p, mainly because of a lower tax benefit from patent box relief and higher amortisation and depreciation. So while EBITDA improved, the benefit did not fully flow through to per-share earnings.
One other note: the prior year was restated because of errors relating to inventory, payables and trademark amortisation. The financial impact was disclosed, and the company says it has added review procedures. It is not catastrophic, but it is never ideal to see tidy-up work like this in final results.
The most strategic announcement here is the new technology platform built around Focusrite’s own proprietary silicon chip, called FAESIC – Focusrite Audio Engineering Specific Integrated Circuit.
This matters for three reasons. First, it should improve product performance. Second, it should make future development more efficient through a shared software platform. Third, it reduces dependence on third-party silicon, which helps de-risk the supply chain and could support margins over time.
The first product using the platform is due later this year, with more to follow over the next three years and beyond. For long-term investors, this is probably the most interesting part of the whole RNS. It suggests Focusrite is trying to build a deeper technology moat rather than just launching the next box with a few new knobs.
Current trading sounds encouraging. The first quarter was ahead of the prior year, and the board said underlying demand remains healthy across both divisions. Guidance for the year to 28 February 2027 is unchanged.
That is the sensible tone. Management is not pretending the macro backdrop is easy, with tariff instability, geopolitical pressure and soft consumer confidence still in the mix. But the business enters the new year with better momentum, stronger margins and lower debt.
My view: this is a good update, not a blockbuster one. The company has shown it can defend margins, generate cash and reduce debt in a messy trading backdrop, which is exactly what you want from a quality small-cap during a tougher patch.
The negatives are real – especially the Sequential impairment, lower adjusted EPS and the prior-year restatement. But the positives outweigh them for me. The core brands look resilient, direct-to-consumer is growing, and the proprietary silicon platform gives the medium-term story more bite.
In short, Focusrite looks like a business that has moved past the post-pandemic comedown and is getting itself back into shape. That does not guarantee a straight line up, but it does make the investment case more interesting again.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
4 viewsLikes
No ratings yet
No comments yet - start the conversation.